Global Blood Screening Market: Overview
A medical process in which the blood is examined for the diagnosis of a specific disease or condition is known as blood screening. With the help of blood screening, one can prevent conditions such as infections and cancer. The common blood screening tests are pregnancy, HIV, and the blood type. Prior to the blood donation, blood donor screening is performed in order to have a check against any infections. There are a number of blood screenings being performed in the laboratories before blood products or blood is being transfused. The blood is thoroughly screened for the detection of diseases such as HIV, syphilis and hepatitis B and C.
Global Blood Screening Market: Segmentation
The blood screening market is globally segmented into technology, products, and services, end-user and region. On the basis of technology, the blood screening market is categorized into the nucleic acid test, rapid tests, next generation sequencing, enzyme-linked immunosorbent assay and western blot assay. The nucleic acid test is further sub-segmented into the real-time polymerase chain reaction and transcription-mediated amplification. Similarly, the enzyme-linked immunosorbent assay is divided by platform and by generation, which is further sub-segmented into colorimetric immunoassay, chemiluminescence immunoassay and fluorescence immunoassay under the platform category and under the generation category, it is sub-segmented as first, second, third, fourth and above. Based on the products and services, the blood screening market is segregated into reagents and kits, standards and controls, buffers, nucleotides and solutions, immunosorbents, conjugates, sample diluents and wash solutions, software and services, enzymes and polymerases, probes and primers, labeling and detection reagents, controls, substrates and instruments. Based on the end user, the market is divided into hospitals and blood banks. Region-wise, the blood screening market is diversified into Asia Pacific, North America, Europe and Rest of the World.
Global Blood Screening Market: Growth Factors
The factors that are driving the blood screening market are the rise in the number of blood donations and the blood donors, increasing number of cases of infectious diseases, the rise in the expenditure on the healthcare, the technological advancements in the blood screening techniques, rise in the initiatives taken by the government, awareness among the people regarding safety of the donated blood, rise in the adoption of the nucleic acid testing and rise in the awareness about the healthcare. The pathogen reduction technology and the multiplex tests are the proving opportunities in the global market. Similarly, there are also factors that are restraining the market growth such as the initial capital cost and operating cost are high, lack of skilled professionals, the alternative technologies are being used and the regulatory frameworks for approval are complex.
Global Blood Screening Market: Regional Analysis
North America dominates the global blood screening market owing to the factors such as occurrences of the infectious diseases are rising and the blood screening techniques in this region are technologically well advanced. The other factors that are contributing to the market growth are strict FDA regulations regarding the transfusion of blood, the presence of the key manufacturers, patients affordability and the growth in the adoption of the blood screening processes are some of the reasons why North America is leading the market. China and India are the leading countries in the Asia Pacific region. The growth in this region is owing to the increase in the number of patients, high disposable income, increase in the government initiatives, improvement in the healthcare infrastructure and the growing demand for the donated blood.
Global Blood Screening Market: Competitive Players
The major market players in the blood screening market include Grifols, Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., bioMérieux, Siemens Healthineers, Beckman Coulter, Inc. and Becton, Dickinson and Company.
Global Blood Screening Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
What Reports Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market
